The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine? Review Abstract The rapid expansion of biomarker discovery and clinical application has created both unprecedented opportunities and substantial challenges in modern medicine. This analysis examines whether the current biomarker boom represents genuine progress
Tag: personalized medicine
Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres
Ageotypes and Modern Longevity Biomarkers: What Physicians Should Monitor Beyond Telomeres Key Takeaways Stanford's ageotypes framework revolutionizes aging assessment by identifying four distinct aging patterns—metabolic, immune, hepatic, and nephrotic—enabling personalized longevity interventions beyond traditional approaches. • Telomeres alone are insufficient: Individual variation and tissue-specific differences
Why Biomarker-Driven Treatment Fails: The Hidden Role of Histology
Why Biomarker-Driven Treatment Fails The Hidden Role of Histology Introduction Biomarker-driven treatment has fundamentally transformed oncology, ushering in an era of precision medicine in which therapeutic decisions are increasingly guided by the molecular characteristics of tumors rather than their anatomical origin alone. A
AI-Powered Clinical Decision Support in Neurology: Help or Hindrance?
AI-Powered Clinical Decision Support in Neurology: Help or Hindrance? Check out our extensive video library (see channel for our latest videos) Abstract This paper examines the application of artificial intelligence (AI) in neurology to assist doctors in making informed decisions about patient care. We
